Farallon Capital Management LLC Capricor Therapeutics, Inc. Transaction History
Farallon Capital Management LLC
- $18.8 Billion
- Q4 2024
A detailed history of Farallon Capital Management LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 2,250,400 shares of CAPR stock, worth $33.8 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
2,250,400Holding current value
$33.8 Million% of portfolio
0.17%Shares
1 transactions
Others Institutions Holding CAPR
# of Institutions
134Shares Held
15.8MCall Options Held
1.83MPut Options Held
1.5M-
Vanguard Group Inc Valley Forge, PA2.28MShares$34.2 Million0.0% of portfolio
-
State Street Corp Boston, MA2.21MShares$33.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$24.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$13.2 Million0.0% of portfolio
-
Altium Capital Management LP New York, NY714KShares$10.7 Million3.29% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $366M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...